FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...

The main difference between collagen and whey protein is their amino acid profile and health benefits. Collagen's amino acids ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...

‘Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial’ by Christian S. Hendershot et al. was published in JAMA Psychiatry at 16:00 UK time on Wednesday 12 February ...

REDWOOD CITY, Calif. - Rezolute , Inc. (NASDAQ:RZLT), a biopharmaceutical company with a market capitalization of $303.62 million and impressive recent momentum (up 13.91% in the past week), announced ...

The STAY study aims to change this reality. Researchers hope that the new drug will slow down the ageing process, improve ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson’s, finds a new study led by UCL researchers.

This work presents potentially important findings suggesting that a combination of transcranial stimulation approaches applied for a short period could improve memory performance after administration.